Cannabis-based products and multiple sclerosis-related pain: The role of routes of administration

Mult Scler Relat Disord. 2023 Sep:77:104863. doi: 10.1016/j.msard.2023.104863. Epub 2023 Jun 29.

Authors

Tangui Barré¹, Damien Testa², Clémence Ramier¹, Melina Santos¹, Fabienne Marcellin¹, Perrine Roux¹, Patrizia Carrieri³, Lise Radoszycki², Camelia Protopopescu¹

Affiliations

¹ Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.
² Carenity, Paris, France.
³ Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France. Electronic address: pmcarrieri@aol.com.

PMID: 37437309
DOI: 10.1016/j.msard.2023.104863

No abstract available

Keywords: Cannabis; France; Inhalation; Multiple sclerosis; Pain.

Publication types

Letter
Comment

MeSH terms

Cannabis* / adverse effects
Dronabinol
Humans
Multiple Sclerosis* / complications
Pain / etiology

Substances

Dronabinol